Dolutegravir leads to weight gain in two African studies
Dolutegravir safety in pregnancy: risk is lower than first reported
Cases of hair loss among African-American women reported after switch to new tenofovir formula
Antiretrovirals do not cause neurodevelopmental harm to uninfected infants
ART for treatment-experienced people with virological failure can omit NRTIs if three active drugs available
The impact of older antiretrovirals on fat redistribution and cardiovascular risk factors may be irreversible
Integrase inhibitor treatment leads to greater weight gain
Neural tube defects and integrase inhibitors: still waiting for stronger evidence
